title: Low-molecular-weight heparins for unstable angina. A better mousetrap?
authors.forename: D
authors.initials: D
authors.lastname: Waters
authors.forename: R R
authors.initials: RR
authors.lastname: Azar
mesh_terms: D000789:Angina, Unstable / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006207:Half-Life; D006493:Heparin / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D013924:Thrombophlebitis / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin